CSI Market
Sign In | Register

Biodelivery Sciences International Inc (BDSI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BDSI Annual Cash Flow →
The data below summarizes Biodelivery Sciences International Inc's cash flow activity from Dec 31 2020 to Dec 31 2021, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Sep 30 2021) (Jun 30 2021) (Mar 31 2021) (Dec 31 2020)
Operating Activities
Income84.86
Depreciation & amortization0.14
Amortization of Other Assets7.28
Accretion Expense0.34
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-6.27
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation6.17
Income (Loss) from Equity Method Investments0.00
Fair Value of Assets Acquired0.00
Derivative Gain Loss On Derivative Net-
Warrant Issuance Expense-
Impairment Of Intangible Assets Excluding Goodwill-
Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings-
Common Stock Shares Issuance Upon Retirement-
Increase Decrease In Operating Lease Assets And Liabilities-0.03
Income taxes-56.53
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-8.72
Increase (Decrease) in Accounts Payable and Accrued Liabilities16.10
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.97
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities41.04
Investing Activities
Capital Expenditures-0.42
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-6.46
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-6.87
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-20.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-11.44
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Increase Decrease In Amounts Due To Related Party Financing Activity-
Return Of Short Swing Profits-
Proceeds From Payments To Issuance Of Common Stock-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-31.44
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow40.62
Total Cash Flow2.73
4 historic quarters locked

Sign in to unlock the full Biodelivery Sciences International Inc cash flow history.

Sign In Create Free Account

About Biodelivery Sciences International Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001103021-22-000051

Figures are derived from filed reports and may be restated. Historical data is subject to revision.